Test Price
2,800 AED✅ Home Collection Available
DCAF17 Gene Sequencing (Woodhouse-Sakati Syndrome) Genetic Test in UAE | 2800 AED | DHA Licensed & ISO Accredited
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% sensitivity via ISO 9001:2015 accredited Next-Generation Sequencing (NGS) processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (daily 8 AM – 11 PM).
- Post-Test Support: Complimentary telephonic clinical guidance to explain results and coordinate care.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The DCAF17 NGS test sequences the entire coding region of the DCAF17 gene to diagnose Woodhouse‑Sakati syndrome – a rare autosomal recessive disorder presenting with hypogonadism, alopecia, diabetes mellitus, intellectual disability and extrapyramidal signs. This test is performed exclusively at our CAP‑accredited laboratory in Dubai Healthcare City.
| Feature | Our Test – DCAF17 NGS | Closest Alternative – Sanger Sequencing |
|---|---|---|
| Method | Next‑Generation Sequencing (NGS) – full gene coverage, variant‑level resolution | Sanger sequencing – single‑exon, lower throughput |
| Diagnostic Precision | 99.9% (ISO‑validated analytical accuracy) | ~99.0% per amplicon; may miss large deletions/duplications |
| Turnaround Time | 3–4 weeks | 6–8 weeks (limited lab capacity) |
| Cost (AED) | 2800 | 4500+ (reagent‑intensive) |
| Pre‑Test Genetic Counselling | Included and mandatory | Often not included |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I understand that receiving a genetic diagnosis can be emotionally challenging. This DCAF17 test provides critical molecular information, yet it must always be interpreted in the context of full clinical evaluation and family history. I strongly recommend that patients and families do not alter any treatments until they consult with their managing physician.”
— Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Advisory
Never discontinue prescribed hormonal therapies or anti‑diabetic agents without consulting your doctor. Sudden withdrawal can lead to serious metabolic imbalances. Always bring a complete list of medications to your appointment.
Safety Exclusion Criteria & ER Red Flags
- Minors: Parental/legal guardian consent is mandatory per UAE Federal Law No. 2 of 2019 concerning health information use. Genetic testing in minors must be medically justified.
- Sample Collection: Home phlebotomy is available only for stable patients. Those with acute medical conditions must provide samples under direct medical supervision in a hospital setting.
- ER Red Flags: If the patient develops severe hypoglycemia, dystonic crisis, or symptoms of adrenal insufficiency (severe weakness, vomiting, hypotension) – proceed immediately to the nearest emergency department and notify the ordering physician.
Patient FAQ & Clinical Guidance
1. What does the DCAF17 gene test detect?
The DCAF17 NGS test detects pathogenic variants linked to Woodhouse‑Sakati syndrome, a disorder with endocrine and neurological features. Full gene sequencing provides comprehensive variant detection.
2. How is the sample collected and what is the turnaround time?
A whole blood, buccal swab, or dried blood spot (FTA card) is collected. Our VIP mobile phlebotomy can visit your home from 8 AM to 11 PM daily. Results are ready in 3–4 weeks.
3. Is genetic counselling required before testing?
Yes, a pre‑test genetic counselling session is mandatory under DHA regulations. During this session we draw a pedigree, discuss inheritance, risks, benefits, and obtain informed consent.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, stored on secure UAE servers, and accessible only to authorised clinical personnel. Patient consent for testing is obtained per Federal Decree-Law No. 4 of 2016 on Medical Liability. Our DHA license (#1143) ensures full adherence to Dubai Healthcare City quality standards.
Clinical & Logistical Metadata
| Test Name | DCAF17 Gene Sequencing (Woodhouse-Sakati Syndrome) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Buccal Swab, or Dried Blood Spot (FTA Card) |
| Methodology Used | Next-Generation Sequencing (NGS) – full gene coding region |
| ICD-10-CM Code | E88.89 (Other specified metabolic disorders) |
| LOINC Code | 21600-8 (Molecular genetics analysis) |
| DHA Facility License & Address | License #1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians